RHBC
CELG

R.H. Bluestein & Co’s Celgene Corp CELG Stock Holding History

R.H. Bluestein & Co’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-4,265
Closed -$380K – 343
2018
Q1 		$380K Sell
4,265
-425
-9% -$40.8K 0.02% 201
2017
Q4 		$489K Sell
4,690
-80,768
-95% -$9.11M 0.03% 149
2017
Q3 		$12.5M Buy
85,458
+82,458
+2,749% +$11.2M 0.68% 41
2017
Q2 		$390K Hold
3,000
– – 0.02% 173
2017
Q1 		$373K Sell
3,000
-6,300
-68% -$754K 0.02% 191
2016
Q4 		$1.08M Buy
9,300
+6,200
+200% +$690K 0.07% 66
2016
Q3 		$324K Buy
3,100
+100
+3% +$10.8K 0.02% 185
2016
Q2 		$296K Hold
3,000
– – 0.02% 183
2016
Q1 		$300K Sell
3,000
-1,675
-36% -$172K 0.02% 195
2015
Q4 		$560K Sell
4,675
-1,000
-18% -$116K 0.04% 119
2015
Q3 		$614K Sell
5,675
-250
-4% -$31K 0.04% 111
2015
Q2 		$686K Buy
5,925
+178
+3% +$20.4K 0.04% 131
2015
Q1 		$663K Buy
5,747
+897
+18% +$107K 0.04% 129
2014
Q4 		$543K Sell
4,850
-2,200
-31% -$232K 0.03% 172
2014
Q3 		$668K Sell
7,050
-3,900
-36% -$352K 0.04% 155
2014
Q2 		$940K Buy
10,950
+6,100
+126% +$464K 0.06% 121
2014
Q1 		$339K Sell
4,850
-1,150
-19% -$91.1K 0.02% 250
2013
Q4 		$507K Sell
6,000
-32,580
-84% -$2.58M 0.03% 192
2013
Q3 		$2.97M Buy
38,580
+32,580
+543% +$2.28M 0.21% 59
2013
Q2 		$351K Buy
+6,000
New +$361K 0.03% 214

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

R.H. Bluestein & Co's CELG Position: Q2 2018 in Review

R.H. Bluestein & Co sold out of Celgene Corp (CELG) in Q2 2018, closing a stake of 4,265 shares — an estimated $380K sold.

R.H. Bluestein & Co first reported a position in CELG in Q2 2013 and held it in 20 quarters. The position peaked at $12.5M in Q3 2017. 1,360 funds tracked by Wall St. Rank hold CELG as of Q2 2018.

  • R.H. Bluestein & Co reported no remaining Celgene Corp position as of Q2 2018 after selling out during the quarter.
  • R.H. Bluestein & Co sold 4,265 Celgene Corp shares in Q2 2018, an estimated $380K.
  • R.H. Bluestein & Co first reported a position in Celgene Corp in Q2 2013 and held it in 20 quarters.
  • R.H. Bluestein & Co's Celgene Corp position peaked at $12.5M in Q3 2017.
  • 1,360 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2018.

Based on R.H. Bluestein & Co's 13F filing for Q2 2018, filed 10 Aug 2018.